Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Phillips

Showing results (1381-1390 of 1,471) with videos related to

Pageof 148
Sort By:
Experimental Neurology|September 23, 1998
Mitochondria in sporadic amyotrophic lateral sclerosisR H Swerdlow, J K Parks, D S Cassarino, et al.
Hemasphere|July 5, 2023
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM StudyWilliam Townsend, Wolfgang Hiddemann, Christian Buske, et al.
Nature Communications|November 18, 2017
An unexpected protein interaction promotes drug resistance in leukemiaAaron Pitre, Yubin Ge, Wenwei Lin, et al.
Mutation Research|July 9, 2013
DNA-repair measurements by use of the modified comet assay: an inter-laboratory comparison within the European Comet Assay Validation Group (ECVAG)Roger W L Godschalk, Clara Ersson, Patrizia Riso, et al.
Nature Cancer|May 26, 2025
Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexiaYoung-Mee Kim, Mark A Sanborn, Shaluah Vijeth, et al.
The Lancet. Haematology|December 18, 2022
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trialKwee Yong, William Wilson, Ruth M de Tute, et al.
BMC Public Health|February 17, 2018
EXPOsOMICS: final policy workshop and stakeholder consultationMichelle C Turner, Paolo Vineis, Eduardo Seleiro, et al.
Blood|January 29, 2021
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic targetEmma Kennedy, Eve Coulter, Emma Halliwell, et al.
Mucosal Immunology|November 28, 2013
Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cellsI H Chan, R Jain, M S Tessmer, et al.
Neuroreport|February 29, 1996
Complete analysis of the presenilin 1 gene in early onset Alzheimer's diseaseM Hutton, F Busfield, M Wragg, et al.
Pageof 148

Showing results (1381-1390 of 1,471) with videos related to

Sort By:
Pageof 148
Experimental Neurology|September 23, 1998
Mitochondria in sporadic amyotrophic lateral sclerosisR H Swerdlow, J K Parks, D S Cassarino, et al.
Hemasphere|July 5, 2023
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM StudyWilliam Townsend, Wolfgang Hiddemann, Christian Buske, et al.
Nature Communications|November 18, 2017
An unexpected protein interaction promotes drug resistance in leukemiaAaron Pitre, Yubin Ge, Wenwei Lin, et al.
Mutation Research|July 9, 2013
DNA-repair measurements by use of the modified comet assay: an inter-laboratory comparison within the European Comet Assay Validation Group (ECVAG)Roger W L Godschalk, Clara Ersson, Patrizia Riso, et al.
Nature Cancer|May 26, 2025
Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexiaYoung-Mee Kim, Mark A Sanborn, Shaluah Vijeth, et al.
The Lancet. Haematology|December 18, 2022
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trialKwee Yong, William Wilson, Ruth M de Tute, et al.
BMC Public Health|February 17, 2018
EXPOsOMICS: final policy workshop and stakeholder consultationMichelle C Turner, Paolo Vineis, Eduardo Seleiro, et al.
Blood|January 29, 2021
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic targetEmma Kennedy, Eve Coulter, Emma Halliwell, et al.
Mucosal Immunology|November 28, 2013
Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cellsI H Chan, R Jain, M S Tessmer, et al.
Neuroreport|February 29, 1996
Complete analysis of the presenilin 1 gene in early onset Alzheimer's diseaseM Hutton, F Busfield, M Wragg, et al.
Pageof 148